Immunology
Sarcoma relapse risk reduced by 43%
A global team of researchers has announced clinical trial results that point to a new immunotherapy treatment option for two of the most common types of soft tissue sarcoma in adults.
A global team of researchers has announced clinical trial results that point to a new immunotherapy treatment option for two of the most common types of soft tissue sarcoma in adults.